Riskpilot← Back to searchSign inGet full accessDean Hjärta AB
ABActiveOrg 5590471339Junivägen 6 AGeneral medical practice activities · NACE 8621Est. 20160 employees
Revenue 2024
SEK 324K
-45% vs 2023
EBITDA margin
43.2%
-67% vs 2023
Equity ratio
83.2%
Financial strength
Net profit 2024
SEK 82K
-72% vs 2023
| Revenue | SEK 324K | -45% |
| EBITDA | SEK 140K | -67% |
| Net profit | SEK 82K | -72% |
| Total assets | SEK 549K | -65% |
| Equity | SEK 457K | -64% |
| Employees | 0 | — |
Legal name
Dean Hjärta AB
Org number
5590471339
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 januari 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets ändamål är att bedriva konsultverksamhet för specialistvård med inriktning på kardiologi, hjärt- och kärlsjukdomar, internmedicin och klinisk fysiologi samt därmed förenlig verksamhet. Vidare ska bolaget äga, förvalta och bedriva handel med värdepapper och fast egendom, samt bedriva annan därmed förenlig verksamhet.
Address
Junivägen 6 A
Email
alayth@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 105 | 316 | 499 | 590 | 324 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 45 | 167 | 339 | 427 | 140 |
| Depreciation & amort. | −0 | −51 | −57 | −57 | −57 |
| EBIT | 45 | 116 | 282 | 370 | 83 |
| Net financials | — | −1 | — | 2 | 21 |
| Profit before tax | 46 | 116 | 282 | 372 | 104 |
| Tax | −10 | −24 | −58 | −77 | −22 |
| Net profit | 36 | 92 | 224 | 295 | 82 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 708 | 875 | 1 184 | 1 560 | 549 |
| Equity | 664 | 756 | 980 | 1 275 | 457 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 44 | 119 | 204 | 285 | 91 |
| Total debt | 44 | 119 | 204 | 285 | 91 |
EBITDA margin
43.2%
This company
15.8%
Market median
+173% vs market
20202024
Equity ratio
83.2%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
17.9%
This company
18.4%
Market median
+3% vs market
20202024
Net profit margin
25.3%
This company
8.1%
Market median
+212% vs market
20202024
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dean Hjärta AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Farah Al-Aieshy | Deputy Chief Executive Officer | 0 companies |
| Ali Aladellie | Deputy Board Member | 0 companies |
| Layth Aladellie | Chairman | 0 companies |